<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04050514</url>
  </required_header>
  <id_info>
    <org_study_id>001072019</org_study_id>
    <nct_id>NCT04050514</nct_id>
  </id_info>
  <brief_title>Side Effects of Mandibular Advancement Devices</brief_title>
  <official_title>Side Effects of Two Different Mandibular Advancement Devices (MAD) in the Treatment of Snoring and Obstructive Sleep Apnea Syndrome (OSAS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleep-related breathing disorders (SBAS) are one of the most common causes of non-restorative
      sleep.

      Sleep therapy options include positive pressure ventilation with continuous positive airway
      pressure (CPAP) masks, mandibular advancement of the mandible with mandibular advancement
      devices (MAD), back restraining, weight reduction, ear, nose and throat surgical procedures,
      bimaxillary or mandibular remodeling osteotomies, and neurostimulation procedures N.
      hypoglossal. In mild to moderate obstructive sleep apnea syndrome (OSAS), MAD, back
      suppression and weight reduction are potential treatment options. This study aims to identify
      possible side effects in the temporomandibular system that occur during nocturnal support of
      a mandibular arch over two years. Two different MADs are compared in terms of construction,
      height (bite elevation) and protrusion mechanics: the H-MAD with an hinge system according to
      Herbst and the SomnoDent Fusion ™ MAD (called F-MAD) with sliding side wings.

      In addition, it is to be evaluated whether hinge system according to Herbst as a
      protrusion-controlling element and the reduction of the splint body for a reduced bite
      elevation leads to a significant reduction of side effects compared to the F-MAD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sleep-related breathing disorders (SBAS), particularly obstructive sleep apnea syndrome
      (OSAS), are one of the most common causes of non-restorative sleep. Disturbances of sleep
      disorders include apneas and hypopneas associated with either or not pharyngeal obstruction
      and hypoventilation. Depending on the type of respiratory disorder present, they are
      associated with hypoxemia and may cause hypercapnia or acidosis The consequences of
      obstructive narrowing of the pharynx are far-reaching. Studies have shown that patients with
      OSAS have comorbidities such as neurological complaints, heart attacks, dementia,
      cardiovascular complaints, myocardial infarction, and a higher mortality rate.

      Sleep fragmentation caused by respiratory disorders during sleep and wakefulness reactions
      (arousals) can lead to daytime sleepiness and concentration disorders. In the longer term
      untreated arousals and apneas are associated with an increased risk for arterial
      hypertension, stroke, myocardial infarction, diabetes mellitus and libido loss.

      OSAS management includes positive pressure ventilation with continuous positive airway
      pressure (CPAP) masks, mandibular advancement of the mandible with mandibular advancement
      devices (MAD), weight loss, ear, nose and throat surgical procedures, bimaxillary or
      mandibular remodeling osteotomies, and neurostimulation procedures of the hypoglossal nerve.

      Several studies have shown that the use of MADs is inferior in reducing the severity of OSAS
      in comparison to CPAP therapy, but its efficacy is comparable and preferred by patients in
      mild to moderate OSAS.

      Due to the forward displacement of the lower jaw for several hours at night, similar symptoms
      as in temporomandibular dysfunction (TMD) patients may occur. The symptoms may be pain or
      stiffness on the masticatory muscles or temporomandibular joints.

      This study aims to identify possible side effects in the temporomandibular system that occur
      during the course of two years of nocturnal MAD delivery. Two different appliance systems are
      compared in terms of construction height (bite elevation) and protrusion mechanics: the H-MAD
      ™ with a hinge system according to Herbst and the SomnoDent Fusion ™ (called F-MAD) with
      sliding side wings.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 21, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Multicenter, randomized two-arm study with active control group, stratified by gender.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Unblinded with respect to the examiner, blinded to the patient and statisticians in the evaluation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change orofacial pain: numeric rating scale (NRS; 0-10)</measure>
    <time_frame>4 weeks, six months, one year, two years</time_frame>
    <description>change of orofacial pain after applying the MAD measured by numeric rating scale (NRS; 0-10, 0: no pain, 10: worst imaginable pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pressure pain points on palpation</measure>
    <time_frame>4 weeks, six months, one year, two years</time_frame>
    <description>number of pressure pain points on palpation of the masticatory muscles and in the area of the temporomandibular joints according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of posterior contact points</measure>
    <time_frame>4 weeks, six months, one year, two years</time_frame>
    <description>change of the number of occluding posterior teeth</description>
  </secondary_outcome>
  <other_outcome>
    <measure>change in sleep quality: Pittsburgh Sleep Quality Index (PSQI, 0-21, &lt; 5: good sleep)</measure>
    <time_frame>4 weeks, six months, one year, two years</time_frame>
    <description>change in sleep quality after applying the MAD measured by Pittsburgh Sleep Quality Index retrospectively asks for a four-week period the incidence of sleep disturbing events, sleep quality assessment, sleep habits, sleep latency and sleep duration, sleeping medication use.</description>
  </other_outcome>
  <other_outcome>
    <measure>change in daytime sleepiness: Epworth Sleepiness Scale (ESS, 0-24, &lt;11 no daytime sleepiness)</measure>
    <time_frame>4 weeks, six months, one year, two years</time_frame>
    <description>Change in daytime sleepiness measured by Epworth Sleepiness Scale. ESS is a short questionnaire for the detection of daytime sleepiness. (ESS, 0-24, &lt;11 no daytime sleepiness)</description>
  </other_outcome>
  <other_outcome>
    <measure>change in oral health-related quality of life: Oral Health Impact profile (OHIP-5) (0-20)</measure>
    <time_frame>4 weeks, six months, one year, two years</time_frame>
    <description>Oral Health Impact profile (OHIP-5) is a measurement tool for assessing the oral health-related quality of life in adults. It consists of 5 questions for functional limitation, physical pain, psychological discomfort, physical disability, social disability</description>
  </other_outcome>
  <other_outcome>
    <measure>change in chronic pain: Graded Chronic Pain Scale (GCPS) questionnaire (0-4)</measure>
    <time_frame>4 weeks, six months, one year, two years</time_frame>
    <description>Graded Chronic Pain Scale (GCPS) questionnaire records pain intensity and the presence of functional or dysfunctional chronic pain. Three subscale scores (characteristic pain intensity, disability score, and the disability points score) are used to classify subjects into 1 of the 5 pain severity grades: grade 0 for no pain, grade 1displays low disability, low intensity, grade 2 displays low disability but high intensity, grade 3 displays high disability,moderately limiting and grade 4 displays high disability and severely limiting.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">194</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <condition>Temporomandibular Disorders</condition>
  <arm_group>
    <arm_group_label>H-MAD, hinge system according to Herbst</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with snoring and OSAS. Therapy with MAD type H-MAD with lateral hinges according to Herbst.
Bite elevation 2 mm interocclusal distance with a lower jaw advancement of 5 mm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>F-MAD, SomnoDent Fusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with snoring and OSAS,Fusion MAD with sliding side wings (F-MAD). Bite elevation 5 mm interocclusal distance with a lower jaw advancement of 5 mm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>H-MAD with a hinge system according to Herbst</intervention_name>
    <description>The randomized grouping into blocks at a ratio of 1: 1 takes place over sealed envelopes containing the allocation key for the respective MAD. The assignment is stratified according to gender because gender is a strong predictor of sleep disorders and also temporomandibular dysfunctions Integration of the MAD (start of treatment) The laboratory-made MAD (F-MAD / H-MAD) is integrated and checked for a comfortable fit. The patient is instructed to always wear the splint during sleep.
All patients receive an extended guide to jaw gymnastics with the instruction to do it in the morning after waking up and in the evening before falling asleep.
Four weeks after incorporation, the titration phase begins, the slow adjustment of mandibular advancement to optimize sleep medical parameters while minimizing unwanted side effects.
Control appointments take place after four weeks, six months, one year and two years after insertion of the MAD</description>
    <arm_group_label>F-MAD, SomnoDent Fusion</arm_group_label>
    <arm_group_label>H-MAD, hinge system according to Herbst</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with medical indication for mandibular protrusion (MAD) due to OSAS

          -  therapy request for snoring

          -  Body Mass Index (BMI) ≤ 35

          -  mandibular protrusion of 5 mm possible

          -  at least 8 remaining teeth or 4 implants per jaw

          -  fixed dentures and stable

          -  removable partial denture, at least support up to the area of the 2nd premolars on
             both sides

          -  business ability and the existence of the signed declaration of consent

        Exclusion Criteria:

          -  polyarthritis

          -  fibromyalgia, neuralgia

          -  central sleep apnea syndrome

          -  untreated generalized periodontitis

          -  chronic dysfunctional pain degree 3-4

          -  long-term use of psychotropics and analgesics (&gt; 4 weeks)

          -  pregnancy

          -  participation in another interventional clinical study (currently up to three months
             before inclusion)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olaf Bernhardt, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medicine Greifswald</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Olaf Bernhardt, Prof.</last_name>
    <phone>+49 3834 8619617</phone>
    <email>obernhar@uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christian Schwahn, Dr.</last_name>
    <phone>+49 3834 867325</phone>
    <email>schwahn@uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dental Office Dr. Krumholz</name>
      <address>
        <city>Frankfurt</city>
        <zip>60313</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emil Krumholz, Dr.</last_name>
      <phone>69-281976</phone>
      <phone_ext>+49</phone_ext>
      <email>email@dr-krumholz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dental Office Dr. Schlieper</name>
      <address>
        <city>Hamburg</city>
        <zip>22607</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Schlieper, Dr.</last_name>
      <phone>40 88 16 9 330</phone>
      <phone_ext>+49</phone_ext>
      <email>joerg@dr-schlieper.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dental Office Dr. Hauschild</name>
      <address>
        <city>Isernhagen</city>
        <zip>30916</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justus Hauschild, Dr.</last_name>
      <phone>511-611688</phone>
      <phone_ext>+49</phone_ext>
      <email>info@drhauschild.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zahnarztpraxis Weststadt</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76135</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susette Schweigert-Gabler, ZÄ</last_name>
      <phone>017696084825</phone>
      <phone_ext>+49</phone_ext>
      <email>susette.schweigert@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dental Office Dr. Kares</name>
      <address>
        <city>Saarbrücken</city>
        <zip>66121</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Horst Kares, Dr.</last_name>
      <phone>681 89 40 18</phone>
      <phone_ext>+49</phone_ext>
    </contact>
    <contact_backup>
      <email>horst@dr-kares.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dental Office Dr. Heckmann</name>
      <address>
        <city>Saarlouis</city>
        <zip>66740</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sascha Heckmann, Dr.</last_name>
      <phone>6831-62339</phone>
      <phone_ext>+49</phone_ext>
      <email>info@hahe.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dental Office Dr. Meyer</name>
      <address>
        <city>Solingen</city>
        <zip>42719</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meyer Alexander, Dr.</last_name>
      <phone>212311922</phone>
      <phone_ext>+49</phone_ext>
      <email>maddocal@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dental Office Dr. Nauert</name>
      <address>
        <city>Sulzbach</city>
        <zip>66280</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrin Nauert, Dr.</last_name>
      <phone>6897-568 568</phone>
      <phone_ext>+49</phone_ext>
      <email>info@dr-nauert.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mund-Zahn-Kiefer-Klinik</name>
      <address>
        <city>Würzburg</city>
        <zip>97070</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nikolaos Giannakopoulos, Priv.Doz.Dr.</last_name>
      <phone>1737373129</phone>
      <phone_ext>+49</phone_ext>
      <email>Giannakopo_N@ukw.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 Nov;94(2):149-58.</citation>
    <PMID>11690728</PMID>
  </reference>
  <reference>
    <citation>Haviv Y, Rettman A, Aframian D, Sharav Y, Benoliel R. Myofascial pain: an open study on the pharmacotherapeutic response to stepped treatment with tricyclic antidepressants and gabapentin. J Oral Facial Pain Headache. 2015 Spring;29(2):144-51. doi: 10.11607/ofph.1408.</citation>
    <PMID>25905532</PMID>
  </reference>
  <reference>
    <citation>Ringqvist M, Walker-Engström ML, Tegelberg A, Ringqvist I. Dental and skeletal changes after 4 years of obstructive sleep apnea treatment with a mandibular advancement device: a prospective, randomized study. Am J Orthod Dentofacial Orthop. 2003 Jul;124(1):53-60.</citation>
    <PMID>12867898</PMID>
  </reference>
  <reference>
    <citation>Perez CV, de Leeuw R, Okeson JP, Carlson CR, Li HF, Bush HM, Falace DA. The incidence and prevalence of temporomandibular disorders and posterior open bite in patients receiving mandibular advancement device therapy for obstructive sleep apnea. Sleep Breath. 2013 Mar;17(1):323-32. doi: 10.1007/s11325-012-0695-1. Epub 2012 Apr 4.</citation>
    <PMID>22477031</PMID>
  </reference>
  <reference>
    <citation>Gesch D, Bernhardt O, Kocher T, John U, Hensel E, Alte D. Association of malocclusion and functional occlusion with signs of temporomandibular disorders in adults: results of the population-based study of health in Pomerania. Angle Orthod. 2004 Aug;74(4):512-20.</citation>
    <PMID>15387030</PMID>
  </reference>
  <reference>
    <citation>Doff MH, Hoekema A, Pruim GJ, Huddleston Slater JJ, Stegenga B. Long-term oral-appliance therapy in obstructive sleep apnea: a cephalometric study of craniofacial changes. J Dent. 2010 Dec;38(12):1010-8. doi: 10.1016/j.jdent.2010.08.018. Epub 2010 Sep 8.</citation>
    <PMID>20831889</PMID>
  </reference>
  <reference>
    <citation>Bacon W, Tschill P, Sforza E, Krieger J. [A device for mandibular advancement in respiratory disorders of sleep. Clinical study]. Orthod Fr. 2000 Dec;71(4):295-302. French.</citation>
    <PMID>11196228</PMID>
  </reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 1, 2019</study_first_submitted>
  <study_first_submitted_qc>August 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2019</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>side effects</keyword>
  <keyword>mandibular advancement device</keyword>
  <keyword>clinical intervention</keyword>
  <keyword>snoring</keyword>
  <keyword>treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 4, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/14/NCT04050514/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

